Related Experiment Video
Updated: Mar 25, 2026
07:43
Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy
Published on: April 28, 2022
3.5K
Photoactivated hypericin is not genotoxic
Jana Feruszová1, Petronela Imreová, Kristína Bodnárová
1Department of Genetics, Faculty of Natural Sciences, Comenius University, Mlynská dolina B1, Ilkovičova 6, 842 15 Bratislava, Slovak Republic. sevcovicova@fns.uniba.sk.
General Physiology and Biophysics
|February 19, 2016
Summary
Photoactivated hypericin (HYP) can cause primary DNA damage in a dose-dependent manner. However, HYP is not mutagenic or clastogenic, indicating it is not genotoxic for photodynamic therapy applications.
Area of Science:
- Photobiology
- Genotoxicity Testing
- Molecular Toxicology
Background:
- Hypericin (HYP) is a photosensitizer with potential therapeutic applications.
- Phototoxicity and genotoxicity are critical safety parameters for photosensitizing agents.
Purpose of the Study:
- To evaluate the photogenotoxicity of hypericin (HYP) across multiple endpoints: primary DNA damage, gene mutations, and chromosome aberrations.
- To determine if photoactivated HYP poses a genotoxic risk.
Main Methods:
- Comet assay for primary DNA damage (single-strand breaks).
- Ames/Salmonella typhimurium assay for gene mutations.
- In vitro mammalian chromosome aberration test for clastogenicity.
Main Results:
- Photoactivated HYP induced primary DNA damage in a dose- and light-intensity-dependent manner.
- No mutagenic effects were observed in Ames tests with S. typhimurium strains (TA97, TA98, TA100).
- Photoactivated HYP did not induce chromosome aberrations in HepG2 cells at tested concentrations.
Conclusions:
- Photoactivated hypericin demonstrates primary DNA damaging potential but lacks mutagenic and clastogenic activity.
- These findings suggest that photoactivated hypericin is not genotoxic.
- The non-genotoxic profile is significant for the safe application of hypericin in photodynamic therapy.
